Portal de investigación
EVOLUCIÓN DEL LUPUS ERITEMATOSO SISTÉMICO EN ESPAÑA.
Datos básicos
- Protocolo:
- RELESSER-PROS
- EUDRACT:
- NCT:
- Centro:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Año de incio:
- 2018
- Año de finalización:
- 2023
Documentos
- No hay documentos
Participantes
-
José Andrés Román Ivorra
Investigador Principal
-
Elena Grau García
Investigador Colaborador
-
Hikmat Charia
Investigador Colaborador
-
Ernesto Tovar Sugrañes
Investigador Colaborador
Grupos
Financiadores - Promotores
Resultados del Ensayo Clínico
Capítulo 10. Artritis psoriásica. Concepto, manifestaciones clínicas, analítica y radiología
FRAGIO, J.; (...); ROMÁN, J.
Capítulo de un Libro. 2019
(18F)FDG-PET-CT in patients with spondylodiscitis: image, clinical and laboratory findings in 10 cases
Bernal, J.; (...); Bello-Arques, P.
Meeting Abstract. 2019
18f-FDG-PET/CT for Giant Cell Arteritis Detection of Large Vessel Vasculitis: What Should We Take into Consideration? Analytical Study of the Arteser Registry
Estrada-Alarcon, Paula V.; (...); Blanco, Ricardo
Meeting Abstract. 2023
A Multicenter Series of Giant Cell Arteritis Patients from Clinical Practice in Treatment with Tocilizumab Compared with Giacta Trial
Goercke, MC; (...); Blanco, R
Meeting Abstract. 2018
ACR/EULAR 2022 Classification Criteria Compared to the ACR 1990 Classification Criteria in the ARTESER Registry of Giant Cell Arteritis
De Miguel, Eugenio; (...); Blanco-Alonso, Ricardo
Meeting Abstract. 2024
ACUTE PARAPARESIS AS CLINICAL PRESENTATION OF VERTEBRAL OSTEOMYELITIS
Fragio-Gil, JJ; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2019-eular.6662. 2019
After JAK Inhibitor Failure, "Switching" or "Cycling"?
Munoz Martinez, Pablo Francisco; (...); Roman Ivorra, Jose Andres
Meeting Abstract. 2023
AFTER JAK INHIBITOR FAILURE, 'SWITCHING' OR 'CYCLING'?
Munoz Martinez, P.; (...); Roman Ivorra, J. A.
Meeting Abstract. 10.1136/annrheumdis-2023-eular.4124. 2023
ANNALYSIS OF PRO-INFLAMMATORY BIOMARKERS IN A POLYMYALGIA RHEUMATICA COHORT DURING THE ACUTE ONSET OF THE DISEASE
Sanjuan, FMO; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2021-eular.3114. 2021
ANTIMALARIAL DRUGS AND ELECTROCARDIOGRAPHIC ALTERATIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS.
Barcena, C. Riesco; (...); Roman Ivorra, J. A.
Meeting Abstract. 10.1136/annrheumdis-2022-eular.2847. 2022
APREMILAST IN MONOTHERAPY OR COMBINED IN NON-ULCER MANIFESTATIONS OF BEHCET'S DISEASE. NATIONAL MULTICENTER STUDY OF 34 REFRACTORY CASES OF CLINICAL PRACTICE
Morant, AH; (...); Blanco, R.
Meeting Abstract. 10.1136/annrheumdis-2020-eular.4720. 2020
Apremilast in Refractory Oral and/or Genital Ulcers in Behcet's Disease. Multicenter Study of 37 Cases
Atienza-Mateo, B; (...); Blanco, R
Meeting Abstract. 2018
Apremilast in refractory orogenital ulcers and other manifestations of Behcet's disease. A national multicentre study of 51 cases in clinical practice
Atienza-Mateo, B.; (...); Blanco, R.
Article. 2020
Apremilast in refractory orogenital ulcers and other manifestations of Behçet's disease. A national multicentre study of 51 cases in clinical practice.
Atienza-Mateo B; (...); Blanco R
Article. 2020
Association of Anti-CarP Levels with Clinical Activity and Serological Profile in Rheumatoid Arthritis
Martinez Calabuig, Pablo; (...); Roman-Ivorra, Jose A.
Meeting Abstract. 2024
AUTOANTIBODY PROFILE ANALYSIS AND ITS ASSOCIATION WITH CLINICAL MANIFESTATIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS
Garcia, EG; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2019-eular.5699. 2019
Autologous stem cell transplantation in systemic sclerosis: 4 cases.
de la Rubia Navarro, Marta, Leal Rodriguez, Samuel, Roman Ivorra, Jose Andres
Article. 10.1016/j.reumae.2025.501810. 2025
Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients.
Iglesias Gómez R; (...); Poveda Andrés JL
Article. 10.1136/ejhpharm-2021-002741. 2021
BASELINE PROFILE OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS ON TREATMENT WITH BELIMUMAB OF A SPANISH MULTICENTER COHORT
Altabas Gonzalez, I.; (...); Rua-Figueroa, I.
Meeting Abstract. 10.1136/annrheumdis-2023-eular.3003. 2023
BELIMUMAB IV EFFECT IN GLUCOCORTICOID TREATMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS
Navarro, MD; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2019-eular.6585. 2019
Cardiovascular Risk Assessment with Carotid Ultrasonography in Addition to the Traditional Cardiovascular Risk Factor in Rheumatoid Arthritis: A Case Control Study
Mazario, RG; (...); Ivorra, JAR
Meeting Abstract. 2020
CARDIOVASCULAR RISK ASSESSMENT WITH CAROTID ULTRASONOGRAPHY IN ADDITION TO THE TRADITIONAL CARDIOVASCULAR RISK FACTORS IN RHEUMATOID ARTHRITIS PATIENTS: A CASE CONTROL STUDY
Mazario, RG; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2020-eular.6420. 2020
Cardiovascular risk assessment with carotid ultrasound in rheumatoid arthritis.
González Mazarío R; (...); Román Ivorra JA
Article. 10.1016/j.medcli.2022.01.017. 2022
CLINICAL AND SEROLOGICAL EVOLUTION OF RHEUMATIC PATIENTS INFECTED BY SARS-COV-2
Navarro, M. De la Rubia; (...); Ivorra, J. A. Roman
Meeting Abstract. 10.1136/annrheumdis-2022-eular.4559. 2022
Clinical trials: their contribution to the efficiency of the clinical management of rheumatoid arthritis.
Escandell CPA, Ivorra JAR
Article. 10.7573/dic.212612. 2019
CLINICAL VARIABILITY IN PATIENTS DIAGNOSED OF JUVENILE IDIOPATHIC ARTHRITIS WITH POSITIVE AND NEGATIVE ANTINUCLEAR ANTIBODIES (ANA)
Torrat Noves, A. M.; (...); Roman Ivorra, J. A.
Meeting Abstract. 10.1136/annrheumdis-2023-eular.5203. 2023
COMORBIDITY CLUSTERS AND THEIR RELATIONSHIP WITH SEVERITY AND OUTCOMES OF THE INDEX DISEASES, IN A LARGE MULTICENTER SYSTEMIC LUPUS ERYTHEMATOSUS COHORT (RELESSER REGISTER)
Rua-Figueroa, I.; (...); Pego-Reigosa, J. M.
Meeting Abstract. 10.1136/annrheumdis-2023-eular.4168. 2023
Comparison between Tocilizumab Prescribed As Monotherapy Versus Combined with Conventional Immunosuppressant Agents in Giant Cell Arteritis Patients
Goercke, MC; (...); Blanco, R
Meeting Abstract. 2018
COMPUTER TOMOGRAPHY GUIDED BIOPSY YIELD IN PYOGENIC VERTEBRAL OSTEOMYELITIS. AN EXAMINATION OF INFLUENCING FACTORS
Fragio-Gil, JJ; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2019-eular.6627. 2019
Concordance Between the QuantiFERON-TB Gold In-Tube and Tuberculin Test for the Diagnosis of Latent Tuberculosis Infection in Patients with Rheumatic Diseases
Perales, CP; (...); Ivorra, JAR
Meeting Abstract. 2020
CONCORDANCE BETWEEN THE QUANTIFERON-TB GOLD IN-TUBE AND TUBERCULIN TEST FOR THE DIAGNOSIS OF LATENT TUBERCULOSIS INFECTION IN PATIENTS WITH RHEUMATIC DISEASES
Perales, CP; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2021-eular.3157. 2021
CONSENSUS ON THE APPLICATION AND CARE OF BROMELAIN-BASED ENZYMATIC DEBRIDEMENT ON BURNS.
Gonzalez, L; (...); Algarra, B
Article. 2024
CORRELATION BETWEEN PATIENT-REPORTED OUTCOMES OF HEALTH-RELATED QUALITY OF LIFE AND CLINICAL ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS
Garcia, EG; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2019-eular.5661. 2019
Corrigendum to "Relationship between structural damage with loss of strength and functional disability in psoriatic arthritis patients" [Clin. Biomech. volume 68 (2019) Pages 169-174/Article Number JCLB 4795].
Olmos CMF; (...); Ivorra JAR
Correction. 10.1016/j.clinbiomech.2019.10.023. 2020
COVID-19 AND JAKI: ANALYSIS AFTER THREE-YEAR PANDEMIC AT A SPANISH TERTIARY CARE HOSPITAL
Munoz Martinez, P.; (...); Roman Ivorra, J. A.
Meeting Abstract. 10.1136/annrheumdis-2023-eular.4263. 2023
CT GUIDED NEEDLE BIOPSY IN VERTEBRAL OSTEOMYELITIS: RELIABILITY ANALYSIS AND STUDY OF WHICH FACTORS COULD INFLUENCE ON THE RESULT
Fragio-Gil, J. J.; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2020-eular.6383. 2020
CT-Guided Needle Biopsy in Vertebral Osteomyelitis: Study of Factors That Could Influence in Culture Yield.
Fragío Gil JJ; (...); Román Ivorra JA
Article. 10.1016/j.reumae.2020.08.007. 2022
CT-Guided Needle Biopsy in Vertebral Osteomyelitis: Study of Factors That Could Influence in Culture Yield
Fragio Gil, Jorge Juan; (...); Roman Ivorra, Jose Andres
Article. 10.1016/j.reuma.2020.08.002. 2022
Decreased DNA hydroxymethylation and increased DNA demethylation are associated with high antioxidant response in systemic lupus erythematosus patients.
Fragío Gil JJ; (...); Román Ivorra JA
Case Reports. 10.1016/j.medcli.2020.10.023. 2021
Development of an application for mobile phones (App) based on the collaboration between the Spanish Society of Rheumatology and Spanish Society of Family Medicine for the referral of systemic autoimmune diseases from primary care to rheumatology.
Urruticoechea-Arana A; (...); Rúa-Figueroa Í
Article. 10.1016/j.reuma.2019.09.001. 2019
Efectiveness of belimumab in the treatment of lupus nephritis: analysis of 8 cases.
de la Rubia Navarro, Marta; (...); Roman Ivorra, Jose Andres
Article. 10.1016/j.medcli.2022.05.003. 2022
Effect of different schemes of androgen deprivation therapy on bone mass density in prostate cancer patients.
Arevalo Ruales, Karla; (...); Roman Ivorra, Jose Andres
Article. 10.1016/j.medcli.2022.03.026. 2023
EFFECTIVENESS OF BELIMUMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS OF A MULTICENTER SPANISH COHORT
Altabas Gonzalez, I.; (...); Rua-Figueroa, I.
Meeting Abstract. 10.1136/annrheumdis-2023-eular.3482. 2023
Effectiveness of Tocilizumab in Cranial and Extracranial Phenotypes of Giant Cell Arteritis: Multicenter Study of 471 Cases
Sanchez-Bilbao, Lara; (...); Blanco, Ricardo
Meeting Abstract. 2021
Effectiveness of Tocilizumab in the Visual Involvement of Giant Cell Arteritis: Multicenter Study of 471 Patients of Clinical Practice
Sanchez-Bilbao, Lara; (...); Blanco, Ricardo
Meeting Abstract. 2021
EFFICACY AND SAFETY OF APREMILAST IN BEHCET DISEASE PATIENTS
Bernabeu, EV; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2020-eular.5330. 2020
EFFICACY AND SAFETY OF BARICITINIB AND TOFACITINIB IN RHEUMATOID ARTHRITIS: DATA FROM REAL-WORLD
Mazario, RG; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2020-eular.6321. 2020
Efficacy of tocilizumab monotherapy after response to combined tocilizumab and methotrexate in patients with rheumatoid arthritis: the randomised JUST-ACT study
Pablos, JL; (...); Rivero, N
Article. 2019
EPIDEMIOLOGY, DIAGNOSIS AND CLINICAL CHARACTERISTICS OF GIANT CELL ARTERITIS IN PATIENTS INCLUDED IN THE ARTESER MULTICENTER STUDY
Sanchez-Costa, J. T.; (...); Blanco, R.
Meeting Abstract. 10.1136/annrheumdis-2022-eular.1313. 2022
Erratum corrige: "Efficacy of tocilizumab monotherapy after response to combined tocilizumab and methotrexate in patients with rheumatoid arthritis: the randomised JUST-ACT study". J.L. Pablos et al.
Pablos JL; (...); Rivero N
Correction. 2020
EXPERIENCE IN REAL-WORLD CONDITIONS OF THE EFFECTIVENESS OFTHEVACCINE AGAINST HERPES ZOSTER
Mas Sanchez, L.; (...); Roman Ivorra, J. A.
Meeting Abstract. 10.1136/annrheumdis-2023-eular.4258. 2023
Expert Recommendations on the Interleukin 6 Blockade in Patients with Rheumatoid Arthritis.
Tornero Molina, Jesus; (...); Sanmarti, Raimon
Article. 10.1016/j.reuma.2018.07.004. 2018
FREQUENCY OF POLYAUTOIMMUNITY IN A TERTIARY HOSPITAL
Garcia, EG; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2019-eular.5582. 2019
Genotype FBN1/Phenotype relationship in a cohort of patients with Marfan syndrome.
Hernándiz A; (...); Sepúlveda P
Article. 10.1111/cge.13879. 2020
Giant Cell Arteritis Subtypes: Data from the ARTESER Registry
De Miguel, Eugenio; (...); Blanco, Ricardo
Meeting Abstract. 2021
Giant Cell Arteritis-Polymyalgia Rheumatica Spectrum Disease: Relation with Neoplasms and Role as a Paraneoplastic Syndrome
Munoz Martinez, Pablo; (...); Roman-Ivorra, Jose A.
Meeting Abstract. 2024
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
Lopez-Isac, E; (...); ASIG
Article. 10.1038/s41467-019-12760-y. 2019
Health-related quality of life in patients with systemic lupus erythematosus: a Spanish study based on patient reports
Ivorra, JAR; (...); Vivas-Consuelo, D
Article. 10.1007/s10067-019-04485-6. 2019
HEALTH-RELATED QUALITY OF LIFE MEASURES IN SPONDYLOARTHROPATY PATIENTS UNDER BIOLOGICAL THERAPIES IN REAL LIFE
Garcia, EG; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2021-eular.2282. 2021
Hyperparathyroidism in patients with low bone mineral density treated with zoledronic acid or denosumab.
Riesco-Bárcena C; (...); Román-Ivorra J
Article. 10.1016/j.medcli.2024.07.020. 2024
IL2 Decrease Is Associated to ANTI-DNA Positivity in Systemic LUPUS Erythematous Patients
Garcia, EG; (...); Ivorra, JAR
Meeting Abstract. 2018
IMPACT OF GENDER IN JAK INHIBITORS PRESCRIPTION: ANALYSIS FROM A SINGLE CENTER COHORT
Garcia, E. Grau; (...); Ivorra, J. A. Roman
Meeting Abstract. 10.1136/annrheumdis-2022-eular.3917. 2022
Incidence and General Clinical Features of Giant Cell Arteritis in the ARTESER Multicenter Study
Sanchez-Costa, Jesus T.; (...); Blanco, Ricardo
Meeting Abstract. 2021
Incidence of Hyperparathyroidism in Patients with Osteoporosis Treated with Zoledronic Acid or Denosumab
Riesco Barcena, Carmen; (...); Roman Ivorra, Jose Andres
Meeting Abstract. 2023
Increase of IL10 and IFNa2 Are Associated to Clinical Activity in Systemic Lupus Erythematous Patients
Grau Garcia, Elena; (...); Roman-Ivorra, Jose A.
Meeting Abstract. 2024
Increased interferon-1a, interleukin-10 and BLyS concentrations as clinical activity biomarkers in systemic lupus erythematosus.
Fernández Matilla M; (...); Román Ivorra JA
Article. 10.1016/j.medcli.2018.12.012. 2019
Influence of the EULAR recommendations for the use of imaging in large vessel vasculitis in the diagnosis of giant cell arteritis: results of the ARTESER register
De Miguel, Eugenio; (...); Blanco, Ricardo
Article. 10.1136/rmdopen-2022-002507. 2022
Influence of the EULAR recommendations for the use of imaging in large vessel vasculitis in the diagnosis of giant cell arteritis: results of the ARTESER register (vol 8, e002507, 2022)
De Miguel, Eugenio; (...); Blanco, Ricardo
Correction. 10.1136/rmdopen-2022-002507corr1. 2023
Is Belimumab Dose Optimization Possible in Patients with Systemic Lupus Erythematosus?: Analysis of This Therapeutic Strategy in a Large Multicenter Cohort of Patients from Spanish Rheumatology Departments
Altabas Gonzalez, Irene; (...); Rua-Figueroa, Inigo
Meeting Abstract. 2023
JAK inhibitors in combination with anti-TNF drugs on difficult-to-treat chronic polyarthritis: a case series.
Leal S; (...); Román-Ivorra JA
Letter. 10.55563/clinexprheumatol/4ao14k. 2024
Kidney transplant from controlled donors following circulatory death: Results from the GEODAS-3 multicentre study
Portoles, JM; (...); Grp GEODAS
Article. 10.1016/j.nefro.2018.07.013. 2019
LAUDES Study: impact of digital ulcers on hand functional limitation, work productivity and daily activities, in systemic sclerosis patients.
Castellví I; (...); Fonollosa V
Article. 10.1007/s00296-019-04436-z. 2019
LONG-TERM FOLLOW-UP OF PRIMARY RAYNAUD'S PHENOMENON COHORT OF 248 PATIENTS
Sanjuan, FMO; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2019-eular.5989. 2019
Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice.
Bykerk VP; (...); Sibilia J
Article. 10.1007/s10067-019-04535-z. 2019
LUPUS NEPHRITIS RESPONSE IN TERMS OF KIDNEY FUNCTION, URINE SEDIMENT AND SEROLOGICAL ACTIVITY AFTER SUBCUTANEOUS BELIMUMAB TREATMENT
De la Rubia Navarro, M.; (...); Ivorra, J. A. Roman
Meeting Abstract. 10.1136/annrheumdis-2022-eular.2944. 2022
Migratory arthralgia as the initial sign of systemic toxicity associated with chronic nitrofurantoin treatment.
Arevalo Ruales, Karla; (...); Martinez Frances, Manuela
Letter. 10.1016/j.reuma.2018.07.006. 2018
Mortality in Patients with Giant Cell Arteritis in Spain: Results from the ARTESER Registry
Molina-Collada, Juan; (...); Blanco-Alonso, Ricardo
Meeting Abstract. 2024
Mortality in patients with giant cell arteritis in Spain: results from the ARTESER registry
Molina-Collada, Juan; (...); ARTESER Project Collaborative Grp, Clara
Article. 10.1186/s13075-024-03468-6. 2025
Multidisciplinary consensus on the use of hydroxychloroquine in patients with systemic lupus erythematosus
Rua-Figueroa, Inigo; (...); Calvo Alen, Jaime
Article. 10.1016/j.reuma.2024.03.005. 2024
Musculoskeletal Manifestations in Patients Diagnosed with Marfan Syndrome
Mas Sanchez, Laura; (...); Roman-Ivorra, Jose A.
Meeting Abstract. 2024
New structural insights into the role of TROVE2 complexes in the on-set and pathogenesis of systemic lupus erythematosus determined by a combination of QCM-D and DPI.
Juste-Dolz A; (...); Maquieira Á
Article. 10.1007/s00216-018-1407-x. 2019
Novel Blood Biomarkers for Response Prediction and Monitoring of Stereotactic Ablative Radiotherapy and Immunotherapy in Metastatic Oligoprogressive Lung Cancer.
Zafra J; (...); Barragán I
Article. 10.3390/ijms25084533. 2024
Patient Decision Aid (PDA) for Patients with Rheumatoid Arthritis Reduces Decisional Conflict and Improves Readiness for Treatment Decision Making.
Pablos JL; (...); Lizán L
Article. 10.1007/s40271-019-00381-y. 2020
PRELIMINAR STUDY OF THERAPY ADHERENCE CONTROLLED BY PRESCRIPTION OF MEDICATION AND SELF-PERCEPTION ADHERENCE OF INFLAMMATORY CHRONIC DISEASE PATIENTS
Garcia, EG; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2019-eular.5937. 2019
Prevalence and clinical characteristics of patients with rheumatoid arthritis with interstitial lung disease using unstructured healthcare data and machine learning
Román Ivorra JA; (...); Castellanos-Moreira R
Article. 10.1136/rmdopen-2023-003353. 2024
PREVALENCE AND COMORBIDITIES OF RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE IN SPAIN: A RETROSPECTIVE ANALYSIS OF ELECTRONIC HEALTH RECORDS USING NATURAL LANGUAGE PROCESSING
Roman Ivorra, J. A.; (...); Lujan Valdes, S.
Meeting Abstract. 10.1136/annrheumdis-2022-eular.5042. 2022
PREVALENCE, DIAGNOSTIC DELAY AND TREATMENT PROFILE OF PATIENTS WITH MONOGENIC AUTOINFLAMMATORY DISEASES IN AN ADULT RHEUMATOLOGY SERVICE OF A TERTIARY HOSPITAL.
Perales, C. Pavez; (...); Ivorra, J. A. Roman
Meeting Abstract. 10.1136/annrheumdis-2022-eular.4143. 2022
PROFILE OF REAL WORLD AXIAL SPONDYLOARTHRITIS PATIENTS REFRACTORY TO ADVANCED THERAPY
Alcantara Alvarez, I; (...); Roman Ivorra, J. A.
Meeting Abstract. 2024
PROFILE OF REFRACTORY RA PATIENTS FOR TARGETED THERAPIES IN REAL LIFE
Garcia, E. Grau; (...); Ivorra, J. A. Roman
Meeting Abstract. 10.1136/annrheumdis-2023-eular.4014. 2023
PROSPECTIVE STUDY OF 24 MONTHS OF EVOLUTION OF A COHORT OF PATIENTS WITH RHUPUS
Cordellat, I. Martinez; (...); Ivorra, J. A. Roman
Meeting Abstract. 10.1136/annrheumdis-2022-eular.3898. 2022
PROSPECTIVE STUDY OF BONE METABOLISM AND FRACTURE INCIDENCE IN SPINAL CORD INJURY PATIENTS DURING A PERIOD OF 24 MONTHS
Cordellat, IM; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2019-eular.5953. 2019
PULMONARY FUNCTION IN PATIENTS DIAGNOSED OF EARLY SYSTEMIC SCLEROSIS: 10 YEARS EXPERIENCE.
Ortiz-Sanjuan, F.; (...); Ivorra, J. A. Roman
Meeting Abstract. 10.1136/annrheumdis-2022-eular.3085. 2022
PULMONARY FUNCTION IN PATIENTS DIAGNOSED OF EARLY SYSTEMIC SCLEROSIS: A NEW TOOL FOR SYSTEMIC SCLEROSIS CLASIFFICATION?
Sanjuan, FMO; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2020-eular.4423. 2020
PULMONARY INVOLVEMENT AND FUNCTIONAL LIMITATION IN SYSTEMIC SCLEROSIS
Rodriguez, JEO; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2019-eular.6576. 2019
Pyogenic Vertebral Osteomyelitis: Outcome Variables Analysis in a 116 Patients Cohort at a Tertiary Hospital during the Last 8 YEARS
Gil, JJF; (...); Ivorra, JAR
Meeting Abstract. 2018
REAL LIFE SAFETY AND SURVIVAL OF TARGETED THERAPIES IN ARTHRITIS PATIENTS OVER AGE OF 65
Grau Garcia, E.; (...); Roman Ivorra, J. A.
Meeting Abstract. 10.1136/annrheumdis-2023-eular.3018. 2023
Real-world Effectiveness and Safety of JAK Inhibitors in Rheumatoid Arthritis: A Single-centre Study
Gonzalez Mazario, Roxana; (...); Roman Ivorra, Jose Andres
Article. 10.1016/j.reuma.2021.08.001. 2022
Real-world Effectiveness and Safety of JAK Inhibitors in Rheumatoid Arthritis: A Single-centre Study.
González Mazarío R; (...); Román Ivorra JA
Article. 10.1016/j.reumae.2021.08.004. 2022
Real-world evidence of tofacitinib in rheumatoid arthritis patients in Spain
Roman Ivorra, Jose A., Llevat, Noelia, Montoro, Maria
Article. 10.5582/ddt.2022.01028. 2022
Refractory RA Patients for Targeted Therapies in Real Life
Grau Garcia, Elena; (...); Roman Ivorra, Jose Andres
Meeting Abstract. 2023
Relation Between Cumulative Damage in Systemic Lupus Erythematosus and Recognised Disability by the National Social Security Institute of Spain (INSS).
Fernández Matilla M; (...); Román Ivorra JA
Article. 10.1016/j.reuma.2019.03.003. 2019
Relationship between structural damage with loss of strength and functional disability in psoriatic arthritis patients.
Feced Olmos CM; (...); Román Ivorra JA
Article. 10.1016/j.clinbiomech.2019.06.009. 2019
RESPONSE OF BEHCET'S REFRACTORY ORAL AND/OR GENITAL ULCERS TO APREMILAST IN COMBINATION VS MONOTHERAPY. NATIONAL MULTICENTER STUDY OF 51 CASES OF CLINICAL PRACTICE
Morant, AH; (...); Blanco, R.
Meeting Abstract. 10.1136/annrheumdis-2020-eular.6246. 2020
Rhupus syndrome: Description of 9 cases with special attention to the HLA-DR genotype
Hurtado, Andres Perez; (...); Ivorraa, Jose Andres Roman
Article. 10.1016/j.medcli.2024.09.006. 2025
RITUXIMAB SAFETY AND PERSISTENCE IN PATIENTS WITH SYSTEMIC AUTOIMMUNE DISEASES
Perales, CP; (...); Ivorra, JAR
Meeting Abstract. 2020
SCORE2 Is Superior to SCORE in Predicting the Presence of Carotid Plaques and Intima-media Thickness in Rheumatoid Arthritis Patients: A Cross-sectional Study with Carotid Ultrasound
Campos Fernandez, Cristina; (...); Roman-Ivorra, Jose A.
Meeting Abstract. 2024
SECONDARY PREVENTION OF VERTEBRAL FRACTURES SUSTAINED EFFICACY OVER TIME
Oller Rodriguez, J. E.; (...); Roman Ivorra, J. A.
Meeting Abstract. 10.1136/annrheumdis-2022-eular.3312. 2022
Serological Evidence of SARS-CoV-2 in Symptomatic Patients Under Biological Treatment in a Rheumatology Service
Perales, CP; (...); Ivorra, JAR
Meeting Abstract. 2020
Study of Bone Metabolism in Patients Diagnosed with Osteogenesis Imperfecta
Ramos Castro, Daniel; (...); Roman-Ivorra, Jose A.
Meeting Abstract. 2024
The impact of disease activity on health-related quality of life in patients with systemic lupus erythematosus.
Grau García E; (...); Román Ivorra JA
Article. 10.1016/j.medcli.2022.11.019. 2023
The role of 18F-FDG PET/CT in early infectious discitis: a case report after a negative MRI.
Fragío-Gil JJ; (...); Román-Ivorra JA
Case Reports. 10.1016/j.radcr.2019.04.006. 2019
THE ROLE OF CXCL4, CXCL8 AND GDF-15 IN SYSTEMIC SCLEROSIS
Rodriguez, JEO; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2020-eular.5019. 2020
The Role of Plasma Calprotectin in Non-infectious Uveitis.
Pascual EV; (...); Ivorra JAR
Article. 10.1080/02713683.2020.1867749. 2021
Thorough assessment of the effectiveness of belimumab in a large Spanish multicenter cohort of systemic lupus erythematosus patients.
Altabás-González I; (...); Rúa-Figueroa I
Article. 10.1093/rheumatology/kead696. 2024
Tocilizumab in Giant Cell Arteritis. National Multicenter Study of 134 Patients of Clinical Practice
Goercke, MC; (...); Blanco, R
Meeting Abstract. 2018
Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice
Calderon-Goercke, M; (...); Blanco, R
Article. 2020
Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice.
Calderón-Goercke M; (...); Blanco R
Article. 2020
TRANSITIONAL CARE IN JUVENILE IDIOPATHIC ARTHRITIS: TIMING, PREVALENCE OF SUBTYPES AND TREATMENT PROFILE IN A SPANISH TERTIARY HOSPITAL.
Perales, C. Pavez; (...); Ivorra, J. A. Roman
Meeting Abstract. 10.1136/annrheumdis-2022-eular.4126. 2022
Treat-to-Target Strategy in Patients with Rheumatoid Arthritis: Audit of Adherence from Real World Clinical Data.
Andréu JL; (...); Gil de Miguel Á
Article. 10.1016/j.reuma.2019.10.006. 2019
USE OF RITUXIMAB IN SYSTEMIC SCLEROSIS PATIENTS WITH PULMONARY AND DIFFUSE CUTANEOUS INVOLVEMENT. A SERIES OF 15 CASES
Ortiz Sanjuan, F.; (...); Roman Ivorra, J. A.
Meeting Abstract. 10.1136/annrheumdis-2023-eular.2961. 2023
Utility of cytokines CXCL4, CXCL8 and GDF15 as biomarkers in systemic sclerosis.
Oller-Rodriguez, Jose E.; (...); Roman Ivorra, Jose A.
Article. 10.1016/j.medcli.2021.12.006. 2022
VERTEBRAL OSTEOMYELITIS IN THE IMMUNOSUPPRESSED PATIENTS
Fragio-Gil, JJ; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2019-eular.6621. 2019
Vertebral osteomyelitis: Clinical, microbiological and radiological characteristics of 116 patients
Gil, JJF; (...); Ivorra, JAR
Article. 10.1016/j.medcli.2019.12.029. 2020
Very Low Disease Activity, DAPSA Remission, and Impact of Disease in a Spanish Population with Psoriatic Arthritis
Queiro, R; (...); Morla, R
Article. 10.3899/jrheum.180460. 2019
Visual Manifestations in Giant Cell Arteritis: Identification of Risk Factors from the ARTESER Registry
Molina-Collada, Juan; (...); Blanco, Ricardo
Meeting Abstract. 2023